Loading…
Loading…
Levi and Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNXPR NewswireNEW YORK, Sept. 30, 2026Th
Nvidia (NVDA) showed the AI trade remains very much alive, says Sylvia Jablonski, along with how important everything that energizes AI really is. She talks about how memory and photonics "fuel the engine" to AI, pointing to several ETFs investors can use to add exposure to portfolios.
DENVER, March 29, 2023 /PRNewswire/ — The Colorado Academy of Physician Assistants (CAPA) names DispatchHealth Co-Founder and Chief Strategy Officer Kevin Riddleberger PA-C, MBA, Colorado’s Physician Assistant (PA) Leader of the Year. The prestigious award recognizes Riddleberger for his contribution to the profession, inspiration to colleagues and patients, professional leadership, high-quality medical care delivery, and community […]...
GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSi” or “the Company”), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has completed its business combination with HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity manager HighCape Capital LP. The business combination and concurrent private placement
Chris Katje is a co-host of Benzinga's YouTube show, "SPACs Attack," with Mitch Hoch. On a recent episode of Benzinga's "SPACs Attack," we offered five long-term SPAC picks for investors to contemplate.
Larry Robbins ( Trades , Portfolio )'s firm has revealed a new buy into HighCape Capital Acquisition Corp. (NASDAQ:CAPA) according to GuruFocus' Real-Time Picks, a Premium feature.
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space. Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market.
A rocket company, a 3-D capture software company, and two biotechs are about to hit the public markets. Smart investors can get in now via special purpose acquisition companies.